JPS61227512A - External preparation for skin - Google Patents
External preparation for skinInfo
- Publication number
- JPS61227512A JPS61227512A JP6880885A JP6880885A JPS61227512A JP S61227512 A JPS61227512 A JP S61227512A JP 6880885 A JP6880885 A JP 6880885A JP 6880885 A JP6880885 A JP 6880885A JP S61227512 A JPS61227512 A JP S61227512A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- protein
- external preparation
- residue
- glycoside
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は、新規な皮膚外用剤に関し、その目的とすると
ころは、皮膚の新陳代謝を活発にし、皮膚の弾力性を増
し、皮膚の保護と水分の保持性に優れた効果を有する皮
膚外用剤を提供するものである。[Detailed Description of the Invention] [Industrial Application Field] The present invention relates to a novel skin preparation for external use, and its purpose is to activate skin metabolism, increase skin elasticity, and protect the skin. An object of the present invention is to provide a skin preparation for external use that has excellent moisture retention effects.
[従来の技術]
皮膚を組織学的に解析すると、真皮にはコラーゲン繊維
と弾力繊維が網状を形成しており、それが皮膚の弾力性
と引っ張り強度をもたらしているとされている。近年、
動物より得られたこれら繊維を科学的処理により可溶性
にしたり、又はこれら繊維から可溶性繊維分子を抽出す
る等により得られたコラーゲンやエラスチンが皮膚の保
護並びに保湿剤として皮膚外用剤に配合されてぎた。ま
た同様の観点からゼラチン、カゼイン、大豆蛋白等の配
合も提案されている。[Prior Art] Histological analysis of the skin shows that collagen fibers and elastic fibers form a network in the dermis, which is said to provide the skin with elasticity and tensile strength. recent years,
Collagen and elastin obtained by making these fibers obtained from animals soluble through scientific treatment, or by extracting soluble fiber molecules from these fibers, have been incorporated into external skin preparations as skin protection and moisturizing agents. . Also, from the same point of view, combinations of gelatin, casein, soybean protein, etc. have also been proposed.
[発明が解決しようとする問題点コ
しかしながらこれら蛋白の皮膚外用剤への単独の配合で
は、その期待される作用効果がいまだ充分ではなく、又
そのため配合量を増加すれば皮膚外用剤の安定性に悪影
響をおよぼすこと、ベタツキが生ずること等の欠点を有
していた。[Problems to be solved by the invention] However, when these proteins are added alone to external skin preparations, the expected effects are still not sufficient, and therefore, increasing the amount incorporated may improve the stability of external skin preparations. It has disadvantages such as having an adverse effect on the product and causing stickiness.
[問題点を解決するための手段]
本発明者等は上記の事情にかんがみ、鋭意研究した結果
、蛋白および蛋白分解物よりなる群から選ばれる一種又
は二種以上と、特定のハイドロキノンの配糖体とを配合
した皮膚外用剤は、水分の保持性が相乗的に増大し、皮
膚を滑かとなし、適度の「潤い」と「はり」を与えこと
を見出し、この知見にもとずいて本発明を完成するに至
った。[Means for Solving the Problems] In view of the above circumstances, the present inventors have conducted intensive research and found that one or more selected from the group consisting of proteins and protein decomposition products, and a specific glycoside of hydroquinone. We have discovered that external skin preparations formulated with the skin synergistically increase water retention, make the skin smooth, and provide appropriate ``moisturization'' and ``firmness.'' Based on this knowledge, we developed this book. The invention was completed.
以下、本発明の構成について詳述する。Hereinafter, the configuration of the present invention will be explained in detail.
本発明に用いられる蛋白および蛋白分解物とは、大豆蛋
白、小麦蛋白、グルテリン、グルカゴン、コラーゲン、
ゼラチン、エラスチン、卵白リゾチーム、アミラーゼ、
フィブリノーゲン、ミオシン、エノラーゼ、キモトリプ
シノーゲン、ヒストン、魚肉蛋白、アビジン、ペプシン
、グロブリン、カゼイン、サクシニル化カゼイン、及び
それらの塩である。The proteins and protein decomposition products used in the present invention include soybean protein, wheat protein, glutelin, glucagon, collagen,
gelatin, elastin, egg white lysozyme, amylase,
These are fibrinogen, myosin, enolase, chymotrypsinogen, histones, fish protein, avidin, pepsin, globulin, casein, succinylated casein, and salts thereof.
本発明の皮膚外用剤にはこれらのうち、一種又は二種以
上が適宜選択され配合される。One or more of these may be appropriately selected and blended into the skin external preparation of the present invention.
蛋白および蛋白分解物の配合量は、本発明の皮膚外用剤
中、0.01〜20重量%、好ましくは、0.01−1
0重量%配合である。The blending amount of protein and protein decomposition product is 0.01 to 20% by weight, preferably 0.01-1% by weight in the skin external preparation of the present invention.
The content is 0% by weight.
配合量が0.01%未満では皮膚に対する保湿効果があ
られれにくり、逆に20%以上加えても効果の増加は実
質上望めないし、ベタツキ等の点で問題が生ずる場合も
あり好ましくない。If the amount is less than 0.01%, the moisturizing effect on the skin will be poor, and if it is added in an amount of 20% or more, no substantial increase in the effect can be expected, and problems such as stickiness may occur, which is not preferable.
本発明に用いられるハイドロキノンの配糖体は下記一般
式であられきれる。The hydroquinone glycoside used in the present invention can be represented by the following general formula.
[式中、Rは三次糖残基、六炭糖残基、アミノ糖残基、
ウロンl!を残基又はそれらのメチル化物を示す。]
式中でRLtL−アラビノース、D−アラビノース、D
−キシロース、D−リボース、L−キシロース、L−リ
キソース、D−リブロース、等の三次糖の残基、D−グ
ルコース、L−ガラクト−ス、D−ガラクトース、D−
マンノース、D−タロース、D−フルクトース、L−ソ
ルボース、D−タガトース、D−プシコースの六炭糖の
残基、D−グルコサミン、D−ガラクトサミン、シアル
酸、アミノウロン酸、ムラミン酸等のアミノ糖の残基、
D−グルクロン酸、D−ガラクツロン酸、D−マンヌロ
ン酸、L−イズロン酸、L−グルロン酸等のウロン酸の
残基又はそれらのメチル化物を示すが、美白効果、入手
の仕易き、安定性、安全性両面からRがD−グルコース
残基の場合、とくにハイドロキノンにD−グルコースが
β−結合した、すなわちハイドロキノンβ−D−グルコ
シド(一般名:アルブチン、以後アルブチンという)が
好ましい。[In the formula, R is a tertiary sugar residue, a hexose sugar residue, an amino sugar residue,
Uron l! indicates the residue or its methylated product. ] In the formula, RLtL-arabinose, D-arabinose, D
- Residues of tertiary sugars such as xylose, D-ribose, L-xylose, L-lyxose, D-ribulose, D-glucose, L-galactose, D-galactose, D-
Hexose residues of mannose, D-talose, D-fructose, L-sorbose, D-tagatose, D-psicose, amino sugars such as D-glucosamine, D-galactosamine, sialic acid, aminouronic acid, and muramic acid. residue,
It refers to residues of uronic acids such as D-glucuronic acid, D-galacturonic acid, D-mannuronic acid, L-iduronic acid, and L-guluronic acid, or their methylated products, and has a whitening effect, easy availability, and stability. When R is a D-glucose residue, it is particularly preferable to use hydroquinone β-D-glucoside (generic name: arbutin, hereinafter referred to as arbutin), in which D-glucose is β-bonded to hydroquinone, from the viewpoint of both properties and safety.
配合量は、皮膚外用剤全量中の0.1〜30重量%であ
り、好ましくは6〜20重量%である。The blending amount is 0.1 to 30% by weight, preferably 6 to 20% by weight, based on the total amount of the skin external preparation.
本発明の皮膚外用剤には上記の必須構成成分に加えて、
必要に応じて、通常医薬品、化粧品分野で用いられるそ
の他の成分、例えばエデト酸、二、三又は四ナトリウム
、クエン酸ナトリウム、メタリン酸ナトリウム等の金属
イオン封鎖剤、ブチルヒドロキシアニソール(BHA)
、ブチルヒドロキシトルエン(BHT)、没食子酸プ
ロピル、dl−α−トコフェロール等の酸か防止剤、界
面活性剤、紫外線吸収剤、香料、水、エタノール、イソ
プロパツール等のアルコール類、増粘剤、色剤、粉末、
薬剤、クエン酸、リンゴ酸等の有機酸、リン酸等の無機
酸等を配合することができる。当然のことながら、これ
らの成分は本発明の効果を損なわない質的量的範囲内で
用いられなければならない。In addition to the above-mentioned essential components, the skin external preparation of the present invention includes:
If necessary, other ingredients commonly used in the pharmaceutical and cosmetic fields, such as edetic acid, sequestering agents such as di-, tri- or tetra-sodium, sodium citrate, sodium metaphosphate, butylated hydroxyanisole (BHA)
, butylated hydroxytoluene (BHT), propyl gallate, acid inhibitors such as dl-α-tocopherol, surfactants, ultraviolet absorbers, fragrances, water, alcohols such as ethanol and isopropanol, thickeners, colorants, powders,
Drugs, organic acids such as citric acid and malic acid, and inorganic acids such as phosphoric acid can be blended. Naturally, these components must be used within a qualitative and quantitative range that does not impair the effects of the present invention.
本発明の皮膚外用剤の剤型は任意であり、溶液系、可溶
化系、乳化系、粉末分散系、水−二層系、水−油一粉末
三層系等、どのような剤型でも構わない。The dosage form of the skin external preparation of the present invention is arbitrary, and any dosage form may be used, such as a solution type, a solubilized type, an emulsion type, a powder dispersion type, a water-two-layer type, a water-oil-one-powder three-layer type, etc. I do not care.
また、本発明の皮膚外用剤の用途も任意であり、化粧水
、乳液、クリーム、バック等のフエーシャル用又はボデ
ィー用皮膚外用剤やヘアトニック、ヘアクリーム、シャ
ンプー、ヘアリンス等の頭髪用皮膚外用剤にもちいるこ
とができる。In addition, the use of the skin external preparation of the present invention is arbitrary, including skin external preparations for facial or body use such as lotions, emulsions, creams, and bags, and external skin preparations for hair such as hair tonics, hair creams, shampoos, and hair rinses. It can also be used.
[実施例]
つぎに実施例および比較例をあげて、本発明を具体的に
明らかにする。本発明はこれにより限定されるものでは
ない。配合量は重量%である。[Examples] Next, examples and comparative examples will be given to specifically clarify the present invention. The present invention is not limited thereby. The blending amount is in weight%.
実施例 1 化粧水 次の処方に従い、常法により化粧水を製造した。Example 1 Lotion A lotion was produced by a conventional method according to the following recipe.
エタノール 8.02−
ピロリドン−5−カルボン酸ナトリウム 2.0ポリオ
キシエチレン(20:eル)
オレイルアルコールエーテル 1.8アルブチ
ン 0.1コラーゲン
0.5プルラン
0.05ホホバ油
0.5苛性カリ
0.015E D T A−3N a
O,01香料
0.1イオン交換水
残量実施例 2 り リ − ム
次の処方に従い、常法によりクリームを゛製造した。Ethanol 8.02-
Sodium pyrrolidone-5-carboxylate 2.0 Polyoxyethylene (20:el) Oleyl alcohol ether 1.8 Arbutin 0.1 Collagen
0.5 pullulan
0.05 jojoba oil
0.5 caustic potash
0.015E DT A-3N a
O,01 fragrance
0.1 ion exchange water
Residual Amount Example 2 Cream A cream was prepared by a conventional method according to the following recipe.
1.3−ブチレングリコール 5.0ポ
リエチレングリコール4000 C。1.3-Butylene glycol 5.0 Polyethylene glycol 4000C.
グリセリン 2.0スクワラ
ン 20.0ワセリン
5.0セトステアリルアル
コール 3.0ポリオキシエチレン(20
モル)
オレイルアルコールエーテル 1.5グリセリ
ールモノステアレート 1.5アルブチン
20.0エラスチン
10.0乳酸ソーダ
2.0キサンタンガム(ケルトロール
商品名) O,OSメチルパラベン
0.1エチルパラベン
0・2苛性カリ
0.01E D T A−3N a
O,01香料
0.2イオン交換水
残量(以下余白)
実施例 3 乳 液
次の処方に従い、常法により乳液を製造した。Glycerin 2.0 Squalane 20.0 Vaseline
5.0 Cetostearyl alcohol 3.0 Polyoxyethylene (20
Mol) Oleyl Alcohol Ether 1.5 Glyceryl Monostearate 1.5 Arbutin
20.0 elastin
10.0 Sodium lactate
2.0 Xanthan gum (Keltrol brand name) O,OS Methylparaben
0.1 ethylparaben
0.2 caustic potash
0.01E DT A-3N a
O,01 fragrance
0.2 ion exchange water
Remaining amount (hereinafter referred to as margin) Example 3 Emulsion A milky lotion was produced by a conventional method according to the following recipe.
グリセリン 2.0スクワラ
ン 5.0ワセリン
1.0セトステアリルアルコ
ール 0.3ポリオキシエチレン(20モ
ル)
オレイルアルコールエーテル 1.5グリセリ
ールモノオレート1.5
アルブチン 10.0ポリ
アクリノ酸ナトリウム 0.03エチルパ
ラベン 0.2ゼラチン
7.0苛性カリ
0.IE D T A−3N a
O,03香料
0.2イオン交換水
残量実施例4 バ ッ り
次の処方に従い、常法によりバックを製造した。Glycerin 2.0 Squalane 5.0 Vaseline
1.0 Cetostearyl alcohol 0.3 Polyoxyethylene (20 mol) Oleyl alcohol ether 1.5 Glyceryl monooleate 1.5 Arbutin 10.0 Sodium polyacrynoate 0.03 Ethyl paraben 0.2 Gelatin
7.0 caustic potash
0. IE D T A-3N a
O,03 fragrance
0.2 ion exchange water
Remaining Amount Example 4 Bag A bag was manufactured by a conventional method according to the following recipe.
プロピレングリコール 2.0ポリエ
チレングリコール4000 3.0グリセリ
ン 15.0エタノール
10.〇へイドロキノンーβ
−D−アラビノース 15.0ポリビニルアルコー
ル 10.0オリーブ油
3.0乳酸
1.0カゼイン
10.0カルボキシメチルセルロース
0.07メチルバラベン 0.
1エチルパラベン 0.1苛性
カリ 0.02EDT
A−3Na O,01香料
0.1イオン交換水
残量実施例5 ヘアクリー
ム
次の処方に従い、常法によりヘアクリームを製造した。Propylene glycol 2.0 Polyethylene glycol 4000 3.0 Glycerin 15.0 Ethanol
10. 〇Hydroquinone-β
-D-arabinose 15.0 Polyvinyl alcohol 10.0 Olive oil
3.0 lactic acid
1.0 casein
10.0 carboxymethylcellulose
0.07 Methylparaben 0.
1 ethylparaben 0.1 caustic potash 0.02 EDT
A-3Na O,01 fragrance
0.1 ion-exchanged water Remaining amount Example 5 Hair cream A hair cream was produced by a conventional method according to the following formulation.
ミツロウ 3.0ワセ
リン 15.0流動パラ
フイン 42.0ポリオキシエ
チレン(5モル)
ステアリン酸エステル 3.0ポリオ
キシエチレン(6モル)
オレイルアルコールエーテル 2.0ポリオキ
シエチレン(6モル)
セチルアノ!コールエーテル 1.0アル
ブチン 7.0エラスチ
ン 5.0精製水
残余香料
適量防腐剤
適量本発明の作用効果にフき、使用テストに
より試験を行った。使用テストは、30名の女性を各3
群に分はパネルとした。第1群には実施例1の化粧水を
、第2群には実施例2のクリームを、第3群には実施例
3の化粧水を使用テストさせた。毎日朝と夜の2回、洗
顔後化粧料を適量顔面に、2週間にわたって、塗布する
ことにより、行った。Beeswax 3.0 Vaseline 15.0 Liquid paraffin 42.0 Polyoxyethylene (5 moles) Stearate 3.0 Polyoxyethylene (6 moles) Oleyl alcohol ether 2.0 Polyoxyethylene (6 moles) Cetylano! Cole ether 1.0 Arbutin 7.0 Elastin 5.0 Purified water
residual fragrance
Appropriate amount of preservative
In view of the effects of the present invention, a proper amount test was conducted. In the usage test, 30 women were tested 3 times each.
Groups were divided into panels. The first group was tested using the lotion of Example 1, the second group was tested using the cream of Example 2, and the third group was tested using the lotion of Example 3. The test was carried out by applying an appropriate amount of cosmetics to the face twice a day, once in the morning and once at night, after washing the face for two weeks.
評価は、下記の3項目につきその有効性を判定した。結
果は表1〜表3に示すとおりである。The evaluation was based on the effectiveness of the following three items. The results are shown in Tables 1 to 3.
(以下余白)
表1
表 2
(以下余白)
表1〜3の結果から明らかなように、本発明の化粧料は
、肌のうるおい、肌のハリ、翌朝のうるおいが感じられ
るようになった。さらに、美白効果にも優れていた。(Hereinafter in the margin) Table 1 Table 2 (Hereinafter in the margin) As is clear from the results in Tables 1 to 3, the cosmetics of the present invention made the skin feel moisturized, firmer, and moisturized the next morning. Furthermore, it also had an excellent whitening effect.
Claims (1)
二種以上と、下記一般式であらわされるハイドロキノン
の配糖体とを配合することを特徴とする皮膚外用剤。 ▲数式、化学式、表等があります▼ [式中、Rは五炭糖残基、六炭糖残基、アミノ糖残基、
ウロン酸残基又はそれらのメチル化物を示す。][Scope of Claims] An external preparation for skin, characterized in that it contains one or more selected from the group consisting of proteins and protein decomposition products, and a glycoside of hydroquinone represented by the following general formula. ▲There are mathematical formulas, chemical formulas, tables, etc.▼ [In the formula, R is a pentose residue, a hexose residue, an amino sugar residue,
Indicates uronic acid residues or their methylated products. ]
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6880885A JPS61227512A (en) | 1985-04-01 | 1985-04-01 | External preparation for skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6880885A JPS61227512A (en) | 1985-04-01 | 1985-04-01 | External preparation for skin |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS61227512A true JPS61227512A (en) | 1986-10-09 |
Family
ID=13384378
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6880885A Pending JPS61227512A (en) | 1985-04-01 | 1985-04-01 | External preparation for skin |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS61227512A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000109417A (en) * | 1998-10-05 | 2000-04-18 | Pola Chem Ind Inc | Cosmetic for improving somber color |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59134706A (en) * | 1983-01-19 | 1984-08-02 | Kobayashi Kooc:Kk | Cosmetic |
JPS6016906A (en) * | 1983-07-07 | 1985-01-28 | Pola Chem Ind Inc | External drug for skin |
-
1985
- 1985-04-01 JP JP6880885A patent/JPS61227512A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59134706A (en) * | 1983-01-19 | 1984-08-02 | Kobayashi Kooc:Kk | Cosmetic |
JPS6016906A (en) * | 1983-07-07 | 1985-01-28 | Pola Chem Ind Inc | External drug for skin |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000109417A (en) * | 1998-10-05 | 2000-04-18 | Pola Chem Ind Inc | Cosmetic for improving somber color |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6096324A (en) | Methods of delivering materials into the skin, and compositions used therein | |
US6579516B1 (en) | Methods of delivering materials into the skin, and compositions used therein | |
JPH07196444A (en) | Composition based on 12c-20c ester and use of it in make-up cleansing | |
KR102610937B1 (en) | Crosslinked hyaluronic acid compositions and method of producing the same | |
JPS61227515A (en) | External preparation for skin | |
JP3443130B2 (en) | External preparation for skin | |
JP2620770B2 (en) | External preparation for skin | |
JPS61227512A (en) | External preparation for skin | |
JP3004707B2 (en) | External preparation for skin | |
JPS61210021A (en) | Hair cosmetic | |
JPH0899861A (en) | Skin external agent | |
JPH041115A (en) | Dermal drug for external use | |
CA2510933C (en) | Methods of delivering materials into the skin, and compositions used therein | |
JPS61207315A (en) | External agent for skin | |
KR102204367B1 (en) | Cosmetic compositions for improving skin wrinkle | |
JPS61227516A (en) | External preparation for skin | |
JPH08268870A (en) | Dermal preparation for external use | |
CA2584797C (en) | Methods of delivering materials into the skin, and compositions used therein | |
JPH09241295A (en) | Skin preparation for external use | |
JPH041116A (en) | Dermal drug for external use | |
JPS61200919A (en) | External drug for skin | |
JPS61227514A (en) | External preparation for skin | |
JPH0217114A (en) | Externally applying agent for skin | |
AU2004202660A1 (en) | Methods of delivering materials into the skin and compositions used therein | |
NZ523505A (en) | Composition containing ceramic calcium phosphate particles for skin application |